MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET 2019-2027

Market By Gender, End-use And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Triton Market Research report states that the Middle East & African infertility (testing and treatment) market is expected to grow in terms of revenue with a CAGR of 6.43% during the forecast period 2019-2027.

The countries scrutinized in the report of infertility (testing and treatment) market in the Middle East & Africa are:

•    United Arab Emirates

•    Turkey

•    Saudi Arabia

•    South Africa

•    Rest of Middle East & Africa.

Report scope can be customized per your requirements. Request For Customization

In-vitro fertilization is the most widely adopted means for infertility treatments in the region and is prominently used by couples with fertility problems, single mothers and others. Increasing government initiatives for the development of healthcare infrastructure, growing lifestyle & gynecological disorders in certain countries of MEA, decreasing rate of pregnancies amongst women and rising population are the factors responsible for the growth of IVF in the region. However, unawareness of advanced fertilization technologies, the high cost required for running the IVF procedure, lack of technical experts and scarcity of advanced in-vitro fertilization methods are expected to restrain the growth of the market. Ethical concerns in many regions of the Middle East have also restrained the market growth.

Technology enables parents to select the baby’s complexion, hair color, gender and so on. However, all of these technological advancements have to undergo tests and pass the regulatory requirements. Over five million babies have been born through IVF technology in the last two decades. With the passage of time, technology is improving, and infertility treatment is improved. Research and development have led to other methods for infertility treatment such as ICSI. The cost of this treatment is high but varies in different countries. In ICSI, the embryologist injects the sperm directly into the cytoplasm or center of the egg for fertilization. In ICSI technology, instead of exposing the egg to thousands of sperm for fertilization, the healthy sperm is injected directly into the egg. Thus, technological advancements will go a long way in boosting the market growth.

Male infertility is defined as the inability of the male to cause pregnancy in a fertile female. It has been seen that males are not open to talking about their experiences as freely as females. The feelings of fertility and sexual competence are closely related in their mind. Most men take virility and infertility to be the same. Often men feel that infertility is a reflection on their sexual competence and that will lead to social ridicule. Thus, a large section of infertile males are reluctant to seek treatment for their infertility issues. This is one of the factors restraining market growth.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    INFERTILITY (TESTING AND TREATMENT) MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   IVF DOMINATES THE FEMALE TREATMENT MARKET

2.2.2.   OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET

2.3. PORTER’S FIVE FORCE ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   INTENSITY OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.   TREATMENT OPTIONS

2.4.2.   QUALITY OF MEDICAL PROCEDURES

2.4.3.   PRICE OF TREATMENTS

2.4.4.   SHIFT TOWARDS MEDICAL TOURISM

2.4.5.   REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.7.1.   RAW MATERIAL PROCUREMENT

2.7.2.   MANUFACTURING

2.7.3.   SUPPLY LOGISTICS

2.7.4.   DISTRIBUTION CHANNELS

2.7.5.   END-USERS

2.8. REGULATORY FRAMEWORK

2.9. MARKET DRIVERS

2.9.1.   RISE IN INFERTILITY AND TREATMENT AWARENESS

2.9.2.   MEDICAL TOURISM IN FERTILITY TREATMENTS

2.9.3.   SURROGACY LAWS ARE GETTING MORE DEFINED

2.9.4.   HEALTHCARE ADVANCES HAVE FINE-TUNED FERTILITY TREATMENT

2.9.5.   INCREASING EFFECTIVENESS OF TREATMENTS

2.9.6.   HEALTHIER DONOR EGGS

2.9.7.   INTRODUCTION OF NEW TESTING DEVICES

2.10.            MARKET RESTRAINTS

2.10.1.                TREATMENT PROCEDURE OUT OF REACH FOR MANY DUE TO HIGH COSTS

2.10.2.                COUNTRY-WISE REGULATORY ISSUES

2.11.            MARKET OPPORTUNITIES

2.11.1.                REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE

2.11.2.                IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS

2.11.3.                DIY TESTING INCREASING ACCESS AND REDUCING COST

2.12.            MARKET CHALLENGES

2.12.1.                INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN

2.12.2.                PERILS OF MULTIPLE PREGNANCIES

2.12.3.                TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS

3.    INFERTILITY (TESTING AND TREATMENT) MARKET OUTLOOK - BY GENDER

3.1. MALE GENDER

3.1.1.   TESTING

3.1.1.1.      DNA FRAGMENTATION

3.1.1.2.      OXIDATIVE STRESS ANALYSIS

3.1.1.3.      SPERM PENETRATION ASSAY

3.1.1.4.      COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5.      SPERM AGGLUTINATION

3.1.1.6.      MICROSCOPIC EXAMINATION

3.1.1.7.      OTHERS

3.1.2.   TREATMENT

3.2. FEMALE GENDER

3.2.1.   FEMALE INFERTILITY TESTING

3.2.1.1.      OVULATION TESTING

3.2.1.2.      HYSTEROSALPINGOGRAPHY

3.2.1.3.      LAPAROSCOPY

3.2.1.4.      TRANSVAGINAL ULTRASOUND

3.2.1.5.      OVARIAN RESERVE TESTING

3.2.1.6.      HORMONAL LEVEL TESTING

3.2.1.7.      OTHERS

3.2.2.   TREATMENT

4.    INFERTILITY (TESTING AND TREATMENT) MARKET OUTLOOK - BY END-USE

4.1. FERTILITY CLINICS

4.2. HOSPITALS

4.3. SURGICAL CENTERS

4.4. CLINICAL RESEARCH INSTITUTES

5.    INFERTILITY (TESTING AND TREATMENT) MARKET - REGIONAL OUTLOOK

5.1.      UNITED ARAB EMIRATES

5.2.      TURKEY

5.3.      SAUDI ARABIA

5.4.      SOUTH AFRICA

5.5.      REST OF MIDDLE EAST & AFRICA

6.    COMPETITIVE LANDSCAPE

6.1. ANDROLOGY SOLUTIONS

6.2. ENDO PHARMACEUTICALS

6.3. PROGYNY

6.4. FERRING PHARMACEUTICALS

6.5. GENEA

6.6. HALOTECH DNA

6.7. IRVINE SCIENTIFIC

6.8. MERCK

6.9. ORIGIO

6.10.            OVASCIENCE

6.11.            VITROLIFE AB        

6.12.            THERMO FISHER SCIENTIFIC, INC.

6.13.            THE COOPER COMPANIES, INC.

6.14.            QUEST DIAGNOSTIC

6.15.            ESCO MICRO PTE. LTD.

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 2:       MARKET ATTRACTIVENESS INDEX

TABLE 3:       VENDOR SCORECARD

TABLE 4:       REGULATORY FRAMEWORK

TABLE 5:       AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 6:       MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY GENDER, 2019-2027, (IN $ MILLION)

TABLE 7:       MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE GENDER, 2019-2027, (IN $ MILLION)

TABLE 8:       MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE INFERTILITY TESTING, 2019-2027, (IN $ MILLION)

TABLE 9:       PROS AND CONS OF DNA SHARING METHODS

TABLE 10:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE GENDER, 2019-2027, (IN $ MILLION)

TABLE 11:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TESTING, 2019-2027, (IN $ MILLION)

TABLE 12:     COST OF OVULATION TESTING KITS IN THE US

TABLE 13:     COST OF HORMONAL TEST IN THE US

TABLE 14:     AVERAGE COST OF SOME INFERTILITY TREATMENTS

TABLE 15:     SOME COMMON DRUG THERAPIES

TABLE 16:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

TABLE 17:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY GENDER, 2019-2027 (IN $ MILLION)

TABLE 18:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE GENDER, 2019-2027 (IN $ MILLION)

TABLE 19:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

TABLE 20:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE GENDER, 2019-2027 (IN $ MILLION)

TABLE 21:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

TABLE 22:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY END-USE, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY END-USER, 2018 & 2027 (IN %)

FIGURE 2:     PORTER’S FIVE FORCE ANALYSIS

FIGURE 3:     KEY BUYING IMPACT ANALYSIS

FIGURE 4:     INDUSTRY COMPONENTS

FIGURE 5:     MAJOR FERTILITY TREATMENT DESTINATION RANKING

FIGURE 6:     CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN

FIGURE 7:     RATE OF MULTIPLE DELIVERIES

FIGURE 8:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE GENDER, 2019-2027 (IN $ MILLION)

FIGURE 9:     MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TESTING, 2019-2027 (IN $ MILLION)

FIGURE 10:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY DNA FRAGMENTATION, 2019-2027 (IN $ MILLION)

FIGURE 11:  CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 12:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OXIDATIVE STRESS ANALYSIS, 2019-2027 (IN $ MILLION)

FIGURE 13:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SPERM PENETRATION ASSAY, 2019-2027 (IN $ MILLION)

FIGURE 14:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2019-2027 (IN $ MILLION)

FIGURE 15:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SPERM AGGLUTINATION, 2019-2027 (IN $ MILLION)

FIGURE 16:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MICROSCOPIC EXAMINATION, 2019-2027 (IN $ MILLION)

FIGURE 17:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 18:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 19:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE GENDER, 2019-2027 (IN $ MILLION)

FIGURE 20:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

FIGURE 21:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OVULATION TESTING, 2019-2027 (IN $ MILLION)

FIGURE 22:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HYSTEROSALPINGOGRAPHY, 2019-2027 (IN $ MILLION)

FIGURE 23:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY LAPAROSCOPY, 2019-2027 (IN $ MILLION)

FIGURE 24:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TRANSVAGINAL ULTRASOUND, 2019-2027 (IN $ MILLION)

FIGURE 25:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OVARIAN RESERVE TESTING, 2019-2027 (IN $ MILLION)

FIGURE 26:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HORMONAL LEVEL TESTING, 2019-2027 (IN $ MILLION)

FIGURE 27:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 28:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 29:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FERTILITY CLINICS, 2019-2027 (IN $ MILLION)

FIGURE 30:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HOSPITALS, 2019-2027 (IN $ MILLION)

FIGURE 31:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SURGICAL CENTERS, 2019-2027 (IN $ MILLION)

FIGURE 32:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY CLINICAL RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)

FIGURE 33:  MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 34:  UNITED ARAB EMIRATES INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 35:  TURKEY INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 36:  SAUDI ARABIA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 37:  SOUTH AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 38:  REST OF MIDDLE EAST & AFRICA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;